Skip to main content
Clinical Trials/CTRI/2024/05/067526
CTRI/2024/05/067526CompletedPhase 2/3

A single arm clinical study to evaluate the efficacy of chaturjataka vati in the management of hyperlipidemia

Dr. Amey Rajendra Ekhande1 site in 1 country35 target enrollmentStarted: May 27, 2024Last updated:

Trial Snapshot

Phase
Phase 2/3
Status
Completed
Sponsor
Enrollment
35
Locations
1
Primary Endpoint
To reduce LDL, Total cholesterol, Triglycerides and Increase HDL levels

Study Overview

Brief Summary

To study the efficacy of Chaturjataka vati in the management of hyperlipidaemia. Total 35 patients will be enrolled. Two tablets of 500 mg will be administered twice a day before food along with the lukewarm water for duration of 60 days and follow up will be done on 20th 40th 60th day and final conclusion will be drawn on the basis of statistical methods.

Study Design

Study Type
Interventional
Allocation
Na
Masking
None

Eligibility Criteria

Ages
30.00 Year(s) to 70.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Age limit from 30 to 70 yrs.
  • Newly detected Hyperlipidemic or known case of Hyperlipidemic patients.

Exclusion Criteria

  • Pregnant women & lactating mothers.
  • Patient with severe renal, hepatic, coronary heart diseases.

Outcomes

Primary Outcomes

To reduce LDL, Total cholesterol, Triglycerides and Increase HDL levels

Time Frame: 60 days study. 20th, 40th, 60th follow up days

Secondary Outcomes

  • 1) To study present day food habits and lifestyle as a causative factor for Hyperlipidemia.(2) To study the concept and role of Agnideepana and Amapachana in the management of)

Investigators

Sponsor
Dr. Amey Rajendra Ekhande
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Dr Amey Rajendra Ekhande

Dr. D. Y. Patil college of Ayurveda and Research center

Study Sites (1)

Loading locations...

Similar Trials